Nail and periungual toxicity following capecitabine therapy

British Journal of Clinical Pharmacology

Volumn 66, Issue 2, 2008, Pages 325-326

  Vaccaro, Mario ^a,b   Barbuzza, Olga ^b   Guarneri, Fabrizio ^a   Guarneri, Biagio ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; GENTAMICIN; PERMANGANATE POTASSIUM;

AGED; CASE REPORT; DERMATITIS; DRUG MECHANISM; DRUG WITHDRAWAL; ERYTHEMA; HAND FOOT SYNDROME; HUMAN; HYPERKERATOSIS; LETTER; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NAIL BED; NAIL DISEASE; ONYCHOLYSIS; ONYCHOMADESIS; PAPULE; PARONYCHIA; PRIORITY JOURNAL; PYOGENIC GRANULOMA; SKIN TOXICITY; STOMACH CANCER; TREATMENT OUTCOME; VASCULAR LESION;

AGED; ANTIMETABOLITES, ANTINEOPLASTIC; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; MALE; NAIL DISEASES; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 47249092773     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2008.03174.x     Document Type: Letter

References (10)

1. Naranjo CA, Busto U, Sellers EM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981 30 : 239 45.
2. Piraccini BM, Iorizzo M. Drug reactions affecting the nail unit: diagnosis and management. Dermatol Clin 2007 25 : 215 21.
3. Walko CM, Lindley C. Capecitabine: a review. Clin Ther 2005 27 : 23 44.
4. Stathopoulos GP, Koutantos J, Lazaki H, Rigatos SK, Stathopoulos J, Deliconstantinos G. Capecitabine (Xeloda) as monotherapy in advanced breast and colorectal cancer: effectiveness and side-effects. Anticancer Res 2007 27 : 1653 6.
5. Minisini AM, Tosti A, Sobrero AF, Mansutti M, Piraccini BM, Sacco C, Puglisi F. Taxane-induced nail changes: incidence, clinical presentation and outcome. Ann Oncol 2003 14 : 333 7.
6. Fox LP. Nail toxicity associated with epidermal growth factor receptor inhibitor therapy. J Am Acad Dermatol 2007 56 : 460 5.
7. Chen GY, Chen YH, Hsu MM, Tsao CJ, Chen WC. Onychomadesis and onycholysis associated with capecitabine. Br J Dermatol 2001 145 : 521 2.
8. Maino KL, Norwood C, Stashower ME. Onycholysis with the appearance of a 'sunset' secondary to capecitabine. Cutis 2003 72 : 234 6.
9. Piguet V, Borradori L. Pyogenic granuloma-like lesions during capecitabine therapy. Br J Dermatol 2002 147 : 1270 2.
10. Chen GY, Chang TW, Chen WC. Exudative hyponychial dermatitis associated with capecitabine and docetaxel combination chemotherapy for metastatic breast carcinoma: report of three cases. Br J Dermatol 2003 148 : 1071 3.